CompletedNot Applicable

Fibre-optic Guided Tracheal Intubation Through SADs

United Kingdom180 participantsStarted 2017-05-24

Plain-language summary

The study aims to establish which of the two second generation Supraglottic Airway Devices, the I-gel or the the laryngeal ask airway (LMA) Protector, is best suited to be used as a conduit to fibreoptic bronchoscope assisted tracheal intubation. The primary outcome of this will be the time to complete the tracheal intubation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • All patients aged above 18, presenting for elective surgical procedure, where a supraglottic airway device can be used and left in place throughout the duration of surgery and requiring tracheal intubation Exclusion Criteria: * Patients who are do not wish to take part * Patients with class II obesity (BMI \>40) * Patients below 18 years of age * American Society of Anaesthesiologists (ASA 3, 4 and 5) * Patients with mouth opening of less than 3 cm * Patients deemed to require awake intubation * Surgery involving head and neck region * Surgery requiring prone position

What they're measuring

Total Intubation Time to Perform Fibreoptic Intubation

Timeframe: less than 3 minutes

Trial details

NCT IDNCT03118596

SponsorUniversity Hospitals Coventry and Warwickshire NHS Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03-26

Results submitted2018-08-15

View on ClinicalTrials.gov More Intubation; Difficult or Failed trials